The Molecular Determinants of Virus Induced Biliary Atresia
The Molecular Determinants of Virus Induced Biliary Atresia
批准号:
8085527
负责人:
GREGORY M TIAO
金额:
$41.41万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2016-03-31
关键词:
Adoptive TransferAmino AcidsAntigen-Presenting CellsAutoimmune ProcessBiliaryBiliary AtresiaBindingBiological AssayCD8B1 geneCOS-7 CellCapsidCell surfaceCellsCharacteristicsChildChildhoodCholestasisComplexDendritic CellsDiseaseDouble Stranded RNA VirusDouble-Stranded RNAEnvironmentEpithelialEpithelial CellsEpitheliumEpitopesEtiologyGene ProteinsGenerationsGenesGeneticGenomeGoalsHepaticImmuneImmune responseImmunoprecipitationIn VitroInbred BALB C MiceInfantInfectionInflammationInjuryKnock-in MouseKnock-outLiverLiver diseasesMHC Class I GenesMacaca mulattaMediatingMessenger RNAMissionModelingMolecularMusMutateMutationNatureNewborn InfantObstructionParentsPathogenesisPeptidesPerinatalPlasmidsPlayProcessProductionPropertyProteinsRecombinantsRestRoleRotavirusRotavirus InfectionsSCID MiceSequence AnalysisSiteStagingT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteT7 RNA polymeraseTestingTranslatingTropismUnited States National Institutes of HealthVaccinia virusViralViral PathogenesisVirusVirus Diseasesbasecholangiocytedisabilityfunctional statusgene cloningin vitro Modelin vivoinsightinterestknockout geneliver transplantationpathogenpositional cloningpromoterprotein aminoacid sequencethree-dimensional modelingtooltreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Biliary atresia is the most common cause of pediatric end stage liver disease and the number one indication for pediatric liver transplantation. Because pathogenic viruses have been found in the liver of afflicted children, a proposed etiology for biliary atresia is a perinatal viral infection triggering immune mediated destruction of the biliary epithelium. The murine model of biliary atresia supports a viral pathogenesis as newborn mice infected with rhesus rotavirus (RRV) develop inflammation within the portal tract and extra- hepatic bile duct obstruction. RRV targets the cholangiocyte for infection and in addition to direct cholangiocyte injury also induces T-cell mediated injury to the biliary epithelium. Rotavirus is a dsRNA virus comprised of 11 gene segments. We hypothesized that specific rotavirus genes govern the ability to infect the cholangiocyte and induce immune mediated injury. To test this hypothesis, we generated a complete set of single gene reassortants derived from the parental strains RRV and TUCH. These reassortants give us a unique set of tools to determine how specific rotavirus genes contribute to the pathogenesis. In preliminary studies, we found that RRV segments 3, 4, 6, 8, 9 and 11 are genes of interest. Given the robust nature of the observations made with gene segment 4, we focused on this gene. We will use in vitro models of RRV - cholangiocyte infection and T-cell activation to determine the mechanisms by which gene segment 4 contributes to disease pathogenesis. We will also use reverse genetics to generate mutate gene segment 4 infectious virus to determine the basis in the more complex environment of the intact host. These complimentary approaches will generate new insight in viral induced biliary atresia.
PUBLIC HEALTH RELEVANCE: Biliary atresia is the most common cause of pediatric end stage liver disease and the number one indication for pediatric liver transplantation. Because pathogenic viruses have been found in the liver of afflicted children, a proposed etiology for biliary atresia is a perinatal viral infection triggering immune mediated destruction of the biliary epithelium resulting in biliary obstruction. Our goal, using a unique set of rotavirus gene knockouts, is to determine the molecular basis for this process. In so doing develop we hope to develop new treatment strategies to alter the course of this challenging disease. This project is in complete accord with the NIH mission to reduce illness and disability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic basis of virus induced Biliary Atresia
-
批准号:10328541
-
项目类别:
-
资助金额:$44.58万
-
财政年份:2011
-
负责人:GREGORY M TIAO
-
依托单位:
The Molecular Determinants of Virus Induced Biliary Atresia
-
批准号:8449192
-
项目类别:
-
资助金额:$34.04万
-
财政年份:2011
-
负责人:GREGORY M TIAO
-
依托单位:
The Molecular Determinants of Virus Induced Biliary Atresia
-
批准号:8243504
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2011
-
负责人:GREGORY M TIAO
-
依托单位:
Intracellular signaling pathways and virus induced biliary atresia
-
批准号:7875916
-
项目类别:
-
资助金额:$7.62万
-
财政年份:2010
-
负责人:GREGORY M TIAO
-
依托单位:
Intracellular signaling pathways and virus induced biliary atresia
-
批准号:8051858
-
项目类别:
-
资助金额:$7.57万
-
财政年份:2010
-
负责人:GREGORY M TIAO
-
依托单位:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
-
批准号:7261173
-
项目类别:
-
资助金额:$12.58万
-
财政年份:2005
-
负责人:GREGORY M TIAO
-
依托单位:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
-
批准号:7121806
-
项目类别:
-
资助金额:$12.69万
-
财政年份:2005
-
负责人:GREGORY M TIAO
-
依托单位:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
-
批准号:6961713
-
项目类别:
-
资助金额:$12.58万
-
财政年份:2005
-
负责人:GREGORY M TIAO
-
依托单位:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
-
批准号:7637736
-
项目类别:
-
资助金额:$12.58万
-
财政年份:2005
-
负责人:GREGORY M TIAO
-
依托单位:
INTRAVENOUS METHYLPREDNISOLONE VS ORAL PREDNISOLONE IN TRANSPLANT REJECTION
-
批准号:7374506
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2005
-
负责人:GREGORY M TIAO
-
依托单位:
Pathogenic Mechanisms of Virus Induced Biliary Atresia
-
批准号:7446561
-
项目类别:
-
资助金额:$12.58万
-
财政年份:2005
-
负责人:GREGORY M TIAO
-
依托单位:
海外基金